BMO Capital Maintains Market Perform on Genpact, Lowers Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Keith Bachman maintains a Market Perform rating on Genpact (NYSE:G) and lowers the price target from $39 to $38.

May 10, 2024 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Genpact's price target has been lowered from $39 to $38 by BMO Capital, though the Market Perform rating is maintained.
A reduction in price target by a reputable analyst firm like BMO Capital can lead to negative investor sentiment in the short term, potentially causing a decrease in stock price. However, the maintenance of a Market Perform rating indicates that the firm does not foresee significant downside from current levels, which might limit the negative impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100